Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market 2026 Outlook: Market Size, CAGR And Key Growth Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market has witnessed significant expansion in recent years. This market is projected to grow from $1.69 billion in 2025 to $2.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.6%. The historical growth trajectory can be attributed to several factors, including the increasing use of intravenous therapies in clinical care, a rising incidence of infusion-related complications, the expansion of hospital patient monitoring systems, the growing adoption of smart infusion devices, and an increased focus on medication safety protocols.
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $4.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.3%. This expansion during the forecast period can be attributed to the wider uptake of AI-driven infusion surveillance, the escalating demand for home-based IV treatment options, the broadened application of predictive patient safety analytics, the enhanced incorporation of networked infusion devices, and a heightened focus on overseeing patient care remotely. Prominent trends expected in the forecast period encompass the greater utilization of real-time IV flow analysis, the increasing deployment of AI for detecting infusion errors, the growing assimilation of intelligent infusion sensors, a broader scope for managing IV therapy remotely, and an intensified commitment to ensuring patient safety and regulatory adherence.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Growth Catalysts And Demand Drivers
The expansion of telehealth services is expected to propel the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market going forward. Telehealth services are healthcare delivery methods that utilize digital communication technologies to provide medical consultations, monitoring, and treatment remotely. Telehealth has expanded due to regulatory changes and reimbursement policies implemented during the COVID-19 pandemic, making virtual healthcare more accessible and financially viable for both providers and patients. Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring supports telehealth services by enabling real-time, remote tracking of patients’ IV therapy, automatically detecting complications, providing actionable insights to healthcare providers, and seamlessly integrating with virtual care platforms to ensure timely interventions, improved patient safety, and more efficient management of home-based and outpatient treatments. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, in 2023, national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the expansion of telehealth services is driving the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market. The proliferation of wearable health technologies is expected to propel the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market going forward. Wearable health technologies refer to devices such as smartwatches and fitness trackers that monitor various health metrics in real time. The adoption of wearable health technologies is rising due to increasing health awareness because more people are actively monitoring their health, tracking vital signs, and seeking tools that provide real-time insights into their well-being. The adoption of wearable health technologies supports remote patient intravenous (IV) monitoring by continuously collecting real-time physiological data from patients, which can be analyzed to detect anomalies, optimize IV treatment, and enable timely, personalized interventions without requiring constant in-person supervision. For instance, in April 2025, according to the UK Parliament’s House of Commons Library, a UK-based government administration, between 2023 and 2024, the NIHR and UKRI invested approximately USD 15 million (£11.5 million) in 10 research projects focused on developing wearable technologies to support greater independence for people living with frailty or long-term physical disabilities. Therefore, the proliferation of wearable health technologies is driving the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market.
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Segment Performance And Emerging Opportunities
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications
4) By End-User: Healthcare Providers, Patients
Subsegments:
1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems
2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software
3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.
View The Full Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Report:
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
